Methods for determining the potency, specificity, and toxicity of hematopoietic prostaglandin D2 synthase

Details for Australian Patent Application No. 2005267920 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Sabol, Jeffrey S.; Cao, Yang; Ayers, Stephen

Agent Watermark

Pub. Number AU-A-2005267920

PCT Pub. Number WO2006/015195

Priority 60/592,501 30.07.04 US

Filing date 28 July 2005

Wipo publication date 9 February 2006

International Classifications

C12Q 1/533 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving isomerase

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

G01N 33/88 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving prostaglandins

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/015195 Priority application(s): WO2006/015195

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267921-Oral care implement

2005267913-Methods and apparatus for improving the accuracy and reach of electronic media exposure measurements systems